Macro_FMN1 displayed an increasing trend post-nICB, whereas Macro_HSPA1A showed a decreasing trend.
← all excerpts
Malevolent alliance of MYBL2<sup>hi</sup> cancer stem cell and SPP1+ macrophage confers resistance to neoadjuvant immunotherapy in bladder cancer.
1
—
—